Abstract
A novel series of 4-chloro-3-arylmaleimide derivatives have been synthesized and evaluated for their cytotoxicity in vitro against human leukemia cell line and four human solid cancer cell lines. Most compounds showed high or mediate activity against the cancer cell lines when compared with bisindolylmaleimide. Among them, 4b is the most promising compound.
Keywords: 4-chloro-3-arylmaleimide, Synthesis, Antitumor activity
Letters in Drug Design & Discovery
Title: Synthesis and Antitumor Activity of Novel 4-Chloro-3-Arylmaleimide Derivatives
Volume: 6 Issue: 1
Author(s): Guiqing Xu, Qiaojun He, Bo Yang and Yongzhou Hu
Affiliation:
Keywords: 4-chloro-3-arylmaleimide, Synthesis, Antitumor activity
Abstract: A novel series of 4-chloro-3-arylmaleimide derivatives have been synthesized and evaluated for their cytotoxicity in vitro against human leukemia cell line and four human solid cancer cell lines. Most compounds showed high or mediate activity against the cancer cell lines when compared with bisindolylmaleimide. Among them, 4b is the most promising compound.
Export Options
About this article
Cite this article as:
Xu Guiqing, He Qiaojun, Yang Bo and Hu Yongzhou, Synthesis and Antitumor Activity of Novel 4-Chloro-3-Arylmaleimide Derivatives, Letters in Drug Design & Discovery 2009; 6 (1) . https://dx.doi.org/10.2174/157018009787158490
DOI https://dx.doi.org/10.2174/157018009787158490 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Personalized Peptide Vaccine for Treatment of Advanced Cancer
Current Medicinal Chemistry Neurotransmitters and Chemokines Regulate Tumor Cell Migration: Potential for a New Pharmacological Approach to Inhibit Invasion and Metastasis Development
Current Pharmaceutical Design Natural Monoclonal Antibodies and Cancer
Recent Patents on Anti-Cancer Drug Discovery Conventional Anticancer Therapeutics and Telomere Maintenance Mechanisms
Current Pharmaceutical Design From Nanotechnology to Nanomedicine: Applications to Cancer Research
Current Molecular Medicine <i>Helicobacter Pylori</i> Interacts with Serum Vitamin D to Influence Hypertension
Current Aging Science Novel Functions and Binding Mechanisms of Carbohydrate-Binding Proteins Determined by Force Measurements
Current Protein & Peptide Science Foldable/Expandable Gastro-retentive Films Based on Starch and Chitosan as a Carrier For Prolonged Release of Resveratrol
Current Pharmaceutical Biotechnology Chitosan: A Propitious Biopolymer for Drug Delivery
Current Drug Delivery Platinum(II) and Palladium(II) Complex Compounds as Anti-cancer Drugs. Methods of Cytotoxicity Determination
Current Pharmaceutical Analysis Polymorphism of UDP-Glucuronosyltransferase and Drug Metabolism
Current Drug Metabolism Editorial: Novel microRNAs as Putative Therapeutic Targets in Cardiovascular Diseases
Current Vascular Pharmacology Nanotheranostics in Evidence Based Personalized Medicine
Current Drug Targets Antiproliferative and Antioxidant Potential of Leaf and Leaf Derived Callus Extracts of Aerva lanata (L.) Juss. Ex Schult. Against Human Breast Cancer (MCF-7) Cell Lines
The Natural Products Journal Nutritional Metabolomics: Lessons from Companion Animals
Current Metabolomics Associations of Body Mass Index and Obesity-Related Genetic Variants with Serum Metabolites
Current Metabolomics Significance of Prion and Prion-Like Proteins in Cancer Development, Progression and Multi-Drug Resistance
Current Cancer Drug Targets Molecules of Infectious Agents as Immunomodulatory Drugs
Current Topics in Medicinal Chemistry Lipid Transport into Bile and Role in Bile Formation
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Prodrugs to Codrugs
Current Drug Therapy